Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 12.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,077,336 shares of the pharmacy operator's stock after acquiring an additional 339,143 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.36% of Walgreens Boots Alliance worth $80,349,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its position in Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 845 shares in the last quarter. Highlander Capital Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Venturi Wealth Management LLC increased its position in Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 981 shares in the last quarter. FinTrust Capital Advisors LLC increased its position in Walgreens Boots Alliance by 2,314.5% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 1,273 shares in the last quarter. Finally, Rocky Mountain Advisers LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. Institutional investors own 58.59% of the company's stock.

Wall Street Analyst Weigh In

WBA has been the subject of a number of research analyst reports. TheStreet upgraded shares of Walgreens Boots Alliance from a "d+" rating to a "c-" rating in a research report on Monday, January 8th. TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a "buy" rating for the company in a research report on Wednesday, April 3rd. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an "underweight" rating for the company in a research report on Monday, April 1st. Truist Financial restated a "hold" rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Finally, Barclays assumed coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They issued an "underweight" rating and a $21.00 price target for the company. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $24.36.

Walgreens Boots Alliance Stock Down 0.2 %

NASDAQ WBA traded down $0.04 on Thursday, hitting $17.59. 6,749,478 shares of the company were exchanged, compared to its average volume of 14,249,341. The company has a market cap of $15.18 billion, a PE ratio of -2.51, a PEG ratio of 1.09 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 12 month low of $17.51 and a 12 month high of $36.14. The stock has a fifty day moving average of $20.50 and a 200-day moving average of $21.95. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period last year, the firm earned $1.16 earnings per share. The business's quarterly revenue was up 6.3% compared to the same quarter last year. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Insider Activity

In other news, Director Valerie B. Jarrett bought 4,456 shares of the stock in a transaction dated Monday, January 29th. The stock was bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Manmohan Mahajan acquired 6,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares of the company's stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Valerie B. Jarrett acquired 4,456 shares of the firm's stock in a transaction that occurred on Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now directly owns 4,456 shares of the company's stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Insiders bought a total of 13,456 shares of company stock worth $270,423 over the last quarter. Insiders own 17.40% of the company's stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.